Efficacy and Safety of 3% Minoxidil Lotion for Beard Enhancement
1 other identifier
interventional
48
1 country
1
Brief Summary
The purpose of this study is to determine efficacy and safety of 3% minoxidil lotion for beard enhancement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Nov 2014
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2014
CompletedFirst Posted
Study publicly available on registry
October 27, 2014
CompletedStudy Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedApril 22, 2015
April 1, 2015
4 months
October 23, 2014
April 21, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
The change of global photographic assessment after 16 weeks from baseline
baseline and 16 weeks
Secondary Outcomes (1)
The change in number of hairs after 16 weeks from baseline
baseline and 16 weeks
Other Outcomes (3)
The change of hair diameter after 16 weeks from baseline
baseline and 16 weeks
Number of participants with adverse events
baseline and 16 weeks
Patient satisfaction by self-assessment questionnaires
baseline and 16 weeks
Study Arms (2)
Minoxidil
EXPERIMENTAL3% Minoxidil lotion is applied twice daily to the beard.
Placebo
PLACEBO COMPARATORPlacebo is applied twice daily to beard.
Interventions
Eligibility Criteria
You may qualify if:
- Healthy male
You may not qualify if:
- serious underlying diseases.
- history of beard/ hair treatment before 6 months
- history of surgery or trauma on beard area.
- history of minoxidil allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MFL University Hospital (Bangkok)
Bangkok, Thailand
Related Publications (3)
Lee S, Tanglertsampan C, Tanchotikul M, Worapunpong N. Minoxidil 2% lotion for eyebrow enhancement: a randomized, double-blind, placebo-controlled, spilt-face comparative study. J Dermatol. 2014 Feb;41(2):149-52. doi: 10.1111/1346-8138.12275. Epub 2013 Nov 8.
PMID: 24471459RESULTSuwanchatchai W, Tanglertsampan C, Pengsalae N, Makornwattana M. Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study. J Dermatol. 2012 Oct;39(10):865-6. doi: 10.1111/j.1346-8138.2012.01579.x. Epub 2012 May 17. No abstract available.
PMID: 22594928RESULTTanglertsampan C. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. J Med Assoc Thai. 2012 Oct;95(10):1312-6.
PMID: 23193746RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Chuchai Tanglertsampan, MD
MFL University Hospital (Bangkok)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assitant Professor
Study Record Dates
First Submitted
October 23, 2014
First Posted
October 27, 2014
Study Start
November 1, 2014
Primary Completion
March 1, 2015
Study Completion
March 1, 2015
Last Updated
April 22, 2015
Record last verified: 2015-04